Style | Citing Format |
---|---|
MLA | Mirsalehi N, et al.. "Congenital Cytomegalovirus Infection in Newborns Suspected of Congenital Rubella Syndrome in Iran: A Cross-Sectional Study." BMC Pediatrics, vol. 24, no. 1, 2024, pp. -. |
APA | Mirsalehi N, Yavarian J, Ghavami N, Naseri M, Khodakhah F, Shatizadeh Malekshahi S, Zadheidar S, Mokhtariazad T, Shafieijandaghi NZ (2024). Congenital Cytomegalovirus Infection in Newborns Suspected of Congenital Rubella Syndrome in Iran: A Cross-Sectional Study. BMC Pediatrics, 24(1), -. |
Chicago | Mirsalehi N, Yavarian J, Ghavami N, Naseri M, Khodakhah F, Shatizadeh Malekshahi S, Zadheidar S, Mokhtariazad T, Shafieijandaghi NZ. "Congenital Cytomegalovirus Infection in Newborns Suspected of Congenital Rubella Syndrome in Iran: A Cross-Sectional Study." BMC Pediatrics 24, no. 1 (2024): -. |
Harvard | Mirsalehi N et al. (2024) 'Congenital Cytomegalovirus Infection in Newborns Suspected of Congenital Rubella Syndrome in Iran: A Cross-Sectional Study', BMC Pediatrics, 24(1), pp. -. |
Vancouver | Mirsalehi N, Yavarian J, Ghavami N, Naseri M, Khodakhah F, Shatizadeh Malekshahi S, et al.. Congenital Cytomegalovirus Infection in Newborns Suspected of Congenital Rubella Syndrome in Iran: A Cross-Sectional Study. BMC Pediatrics. 2024;24(1):-. |
BibTex | @article{ author = {Mirsalehi N and Yavarian J and Ghavami N and Naseri M and Khodakhah F and Shatizadeh Malekshahi S and Zadheidar S and Mokhtariazad T and Shafieijandaghi NZ}, title = {Congenital Cytomegalovirus Infection in Newborns Suspected of Congenital Rubella Syndrome in Iran: A Cross-Sectional Study}, journal = {BMC Pediatrics}, volume = {24}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Mirsalehi N AU - Yavarian J AU - Ghavami N AU - Naseri M AU - Khodakhah F AU - Shatizadeh Malekshahi S AU - Zadheidar S AU - Mokhtariazad T AU - Shafieijandaghi NZ TI - Congenital Cytomegalovirus Infection in Newborns Suspected of Congenital Rubella Syndrome in Iran: A Cross-Sectional Study JO - BMC Pediatrics VL - 24 IS - 1 SP - EP - PY - 2024 ER - |